Annuncio • Dec 30
Bluechiip Limited, Annual General Meeting, Jan 30, 2025 Bluechiip Limited, Annual General Meeting, Jan 30, 2025. Location: at offices of phillips ormonde fitzpatrick, level 16, 333 collins street, melbourne, vic 3000 Australia Reported Earnings • Aug 31
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: AU$0.005 loss per share. Revenue: AU$484.7k (down 47% from FY 2023). Net loss: AU$5.81m (loss widened 15% from FY 2023). Revenue missed analyst estimates by 49%. Earnings per share (EPS) exceeded analyst estimates by 2.0%. Revenue is forecast to grow 78% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Electronic industry in Australia. Buy Or Sell Opportunity • Jul 11
Now 25% undervalued after recent price drop Over the last 90 days, the stock has fallen 36% to AU$0.0045. The fair value is estimated to be AU$0.006, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 57% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 914% in 2 years. Earnings are forecast to grow by 86% in the next 2 years. Annuncio • Jul 05
Bluechiip Limited Announces Company Secretary Changes Bluechiip Limited announced that Ms Chelsea Sheridan of Automic Group has resigned as Company Secretary of the Company. Ms Sheridan tendered her resignation from Automic Group and will be replaced by Patricia Vanni of Automic Group as Company Secretary effective immediately. Breakeven Date Change • May 08
No longer forecast to breakeven The analyst covering Bluechiip no longer expects the company to break even during the foreseeable future. The company was expected to make a profit of AU$400.0k in 2026. New forecast suggests the company will make a loss of AU$100.0k in 2026. New Risk • Mar 01
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: AU$5.9m Forecast net loss in 2 years: AU$245k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$720k revenue, or US$468k). Market cap is less than US$10m (AU$6.40m market cap, or US$4.16m). Minor Risk Currently unprofitable and not forecast to become profitable over next 2 years (AU$245k net loss in 2 years). New Risk • Feb 13
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$915k revenue, or US$597k). Market cap is less than US$10m (AU$6.40m market cap, or US$4.17m). Annuncio • Feb 12
Bluechiip Limited has completed a Follow-on Equity Offering in the amount of AUD 0.835142 million. Bluechiip Limited has completed a Follow-on Equity Offering in the amount of AUD 0.835142 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 119,306,069
Price\Range: AUD 0.007
Discount Per Security: AUD 0.00049
Transaction Features: Subsequent Direct Listing New Risk • Dec 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$15.0m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.3m free cash flow). Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$915k revenue, or US$602k). Market cap is less than US$10m (AU$15.0m market cap, or US$9.83m). Minor Risk Shareholders have been diluted in the past year (31% increase in shares outstanding). Annuncio • Oct 28
Bluechiip Limited, Annual General Meeting, Nov 30, 2023 Bluechiip Limited, Annual General Meeting, Nov 30, 2023, at 14:00 AUS Eastern Standard Time. Location: The Offices of Phillips Ormonde Fitzpatrick Level 16, 333 Collins Street, Melbourne, VIC 3000 Melbourne Australia Agenda: To discuss Financial statements and reports; to discuss Remuneration Report; to discuss Re-election of Directors; to consider ASX Listing Rule 7.1A Approval of Future Issue of Securities; to consider Approval of Issue of Performance Rights to Andrew McLellan, CEO and Managing Director; to consider Approval of Issue of Shares to Related Party, Iain Kirkwood, Non-Executive Chair pursuant to the May Private Placement; to consider Approval of Issue of Shares to Related Party, Iain Kirkwood, Non-Executive Chair pursuant to the October Private Placement; to discuss Ratification of Prior Issue of Shares; and to consider other matters. New Risk • Oct 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.3m (US$9.00m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.3m free cash flow). Share price has been highly volatile over the past 3 months (20% average weekly change). Earnings have declined by 4.9% per year over the past 5 years. Revenue is less than US$1m (AU$915k revenue, or US$577k). Market cap is less than US$10m (AU$14.3m market cap, or US$9.00m). Minor Risk Shareholders have been diluted in the past year (19% increase in shares outstanding). Annuncio • Oct 19
Bluechiip Limited has completed a Follow-on Equity Offering in the amount of AUD 1.63177 million. Bluechiip Limited has completed a Follow-on Equity Offering in the amount of AUD 1.63177 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 73,417,615
Price\Range: AUD 0.021
Discount Per Security: AUD 0.00126
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 4,285,716
Price\Range: AUD 0.021
Discount Per Security: AUD 0.00126
Transaction Features: Subsequent Direct Listing Reported Earnings • Sep 02
Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.005 loss in FY 2022) Full year 2023 results: AU$0.007 loss per share (further deteriorated from AU$0.005 loss in FY 2022). Revenue: AU$915.0k (down 1.3% from FY 2022). Net loss: AU$5.04m (loss widened 65% from FY 2022). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$3.4m free cash flow). Earnings have declined by 5.1% per year over the past 5 years. Revenue is less than US$1m (AU$1.3m revenue, or US$814k). Market cap is less than US$10m (AU$14.3m market cap, or US$9.25m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). New Risk • Jun 27
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$3.4m free cash flow). Earnings have declined by 5.1% per year over the past 5 years. Revenue is less than US$1m (AU$1.3m revenue, or US$839k). Market cap is less than US$10m (AU$14.9m market cap, or US$9.98m). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (19% increase in shares outstanding). Reported Earnings • Mar 03
First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in 1H 2022) First half 2023 results: AU$0.003 loss per share (in line with 1H 2022). Revenue: AU$520.6k (up 171% from 1H 2022). Net loss: AU$2.12m (loss widened 40% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Andrew Cox was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Annuncio • Oct 26
Bluechiip Limited, Annual General Meeting, Nov 28, 2022 Bluechiip Limited, Annual General Meeting, Nov 28, 2022, at 10:00 AUS Eastern Standard Time. Location: The offices of Phillips Ormonde Fitzpatrick Level 16, 333 Collins Street, Melbourne Vic Victoria Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended June 2022 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider Re-election of Michael Ohanessian as Director; to consider ASX Listing Rule 7.1A Approval of Future Issue of Securities under the Performance Rights Plan; to consider Issue of Incentive Securities under the Performance Rights Plan; and to consider other matters. Annuncio • Oct 01
Bluechiip Limited Melbourne VIC Ordinary Shares to Be Deleted from OTC Equity Bluechiip Limited Melbourne VIC Ordinary Shares (Australia) will be deleted from OTC Equity Effective from October 03, 2022, due to Inactive Security. Reported Earnings • Aug 26
Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.005 loss in FY 2021) Full year 2022 results: AU$0.005 loss per share (vs AU$0.005 loss in FY 2021). Revenue: AU$927.2k (up AU$876.1k from FY 2021). Net loss: AU$3.06m (loss narrowed 5.2% from FY 2021). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Andrew Cox was the last director to join the board, commencing their role in 2017. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 02
First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind First half 2022 results: AU$0.003 loss per share (vs AU$0.003 loss in 1H 2021). Net loss: AU$1.52m (loss narrowed 25% from 1H 2021). Revenue missed analyst estimates by 62%. Earnings per share (EPS) exceeded analyst estimates by 10.0%. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings. Reported Earnings • Sep 03
Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in FY 2020) Full year 2021 results: Net loss: AU$3.23m (loss narrowed 28% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 21% per year, which means it is performing significantly worse than earnings. Annuncio • Jun 25
Bluechiip and Labcon Reach $1.6 Million Settlement Bluechiip and Labcon are happy to announce a mutually-beneficial resolution to their disputes as set forth in the litigation filed in the United States District Court for the Northern District of California captioned Bluechiip Limited v. Labcon, North America, et al., No. 3:20-cv-5205-RS. As a part of this resolution: Labcon has agreed to provide Bluechiip with $1.6 million, comprising: an $850,000 cash payment, and: Return of $750,000 worth of Bluechiip delta tags and products previously sold to and paid for by Labcon. These will be incorporated or repurposed into the newest generation of Bluechiip Products, including Bluechiip s new range of Bluechiip Enabled consumables. In addition, Labcon and Bluechiip have entered a new Supply Agreement for the new Bluechiip Enabled consumables, readers, and software. Bluechiip will provide a credit of up to $1,350,000 on sales under this new supply arrangement. Andrew McLellan, Bluechiip Managing Director, said he was delighted that Bluechiips commercial relationship with Labcon would continue.